Goldman Sachs’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $870K | Sell |
350,644
-128,743
| -27% | -$319K | ﹤0.01% | 3931 |
|
|
2025
Q1 | $743K | Sell |
479,387
-4,449
| -0.9% | -$6.9K | ﹤0.01% | 4015 |
|
|
2024
Q4 | $1.04M | Buy |
483,836
+202,820
| +72% | +$434K | ﹤0.01% | 3901 |
|
|
2024
Q3 | $1.22M | Buy |
281,016
+217,896
| +345% | +$948K | ﹤0.01% | 3649 |
|
|
2024
Q2 | $294K | Sell |
63,120
-270,128
| -81% | -$1.26M | ﹤0.01% | 4225 |
|
|
2024
Q1 | $1.69M | Buy |
333,248
+287,263
| +625% | +$1.46M | ﹤0.01% | 3301 |
|
|
2023
Q4 | $129K | Buy |
+45,985
| New | +$129K | ﹤0.01% | 4422 |
|
|
2023
Q2 | – | Sell |
-36,679
| Closed | -$69.3K | – | 4943 |
|
|
2023
Q1 | $69.3K | Sell |
36,679
-327
| -0.9% | -$618 | ﹤0.01% | 4721 |
|
|
2022
Q4 | $66.6K | Sell |
37,006
-17,972
| -33% | -$32.4K | ﹤0.01% | 4753 |
|
|
2022
Q3 | $93K | Sell |
54,978
-47,148
| -46% | -$79.8K | ﹤0.01% | 4938 |
|
|
2022
Q2 | $251K | Sell |
102,126
-78,971
| -44% | -$194K | ﹤0.01% | 4787 |
|
|
2022
Q1 | $502K | Buy |
181,097
+48,941
| +37% | +$136K | ﹤0.01% | 4564 |
|
|
2021
Q4 | $704K | Buy |
132,156
+6,050
| +5% | +$32.2K | ﹤0.01% | 4278 |
|
|
2021
Q3 | $1.07M | Sell |
126,106
-67,356
| -35% | -$570K | ﹤0.01% | 3925 |
|
|
2021
Q2 | $2.36M | Buy |
193,462
+108,934
| +129% | +$1.33M | ﹤0.01% | 3373 |
|
|
2021
Q1 | $2.05M | Buy |
84,528
+12,272
| +17% | +$298K | ﹤0.01% | 3349 |
|
|
2020
Q4 | $2.32M | Buy |
72,256
+64,384
| +818% | +$2.06M | ﹤0.01% | 2984 |
|
|
2020
Q3 | $238K | Sell |
7,872
-9,145
| -54% | -$276K | ﹤0.01% | 4004 |
|
|
2020
Q2 | $718K | Sell |
17,017
-73,020
| -81% | -$3.08M | ﹤0.01% | 3412 |
|
|
2020
Q1 | $2.25M | Buy |
+90,037
| New | +$2.25M | ﹤0.01% | 2693 |
|